Your browser doesn't support javascript.
loading
Cardiometabolic risk reduction after metabolic surgery.
Pareek, Manan; Bhatt, Deepak L.
Afiliação
  • Pareek M; Brigham and Women's Hospital Heart & Vascular Center, Harvard Medical School, Boston, Massachusetts.
  • Bhatt DL; Department of Internal Medicine, Yale New Haven Hospital, Yale University School of Medicine, New Haven, Connecticut, USA.
Curr Opin Cardiol ; 34(6): 663-672, 2019 11.
Article em En | MEDLINE | ID: mdl-31524661
PURPOSE OF REVIEW: Metabolic surgery provides the largest and most durable weight loss in persons with obesity. There is abundant randomized evidence to show its superiority over medical treatment alone in achieving improved glycemic control. RECENT FINDINGS: Recent trials have also demonstrated a significant reduction in cardiovascular risk factor burden, whereas data from observational studies suggest an ability to reduce overt cardiovascular events and mortality. SUMMARY: In this review, we briefly describe the surgical procedures involved and their indications. We further provide a summary of the effects of metabolic surgery on weight loss, glycemic control, and clinical outcomes.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Cirurgia Bariátrica / Obesidade Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Curr Opin Cardiol Assunto da revista: CARDIOLOGIA Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Cirurgia Bariátrica / Obesidade Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Curr Opin Cardiol Assunto da revista: CARDIOLOGIA Ano de publicação: 2019 Tipo de documento: Article